Skip to content
Search

Latest Stories

PSNC seeks pharmacy representation in Integrated Care Systems

Pharmaceutical Services Negotiating Committee has called for a fair representation of pharmacy and other primary care providers in new health and care systems.

The Health and Care Bill that is currently being considered in parliament would shift the responsibility for managing contracts for primary NHS services to new Integrated Care boards (ICBs).


The Bill specifies that ICBs include a member nominated by General Practice, which accounts for only a third of the primary care workforce in England.

In its current form, the Bill has no provision for representation from other primary care professions.

PSNC chief executive Simon Dukes, along with the leaders of the British Medical Association, British Dental Association, Optometric Fees Negotiating Committee and National Community Hearing Association, has written to the Health and Care Bill Committee members, raising concerns about these proposals.

Dukes said: “All primary care providers must have a voice in the new Integrated Care Systems, including community pharmacies and their teams. Every day around 1.6 million people visit a pharmacy in England to access vital medicines, healthcare advice and other important services, such as NHS flu vaccinations."

He added that public reliance on pharmacies increased during the pandemic, therefore it is vital that “these new local systems recognise the critical role played by pharmacies and the whole of primary care, as well as general practice.”

The joint communication calls on the government to ensure:

  • Primary care is represented and involved in decision-making at all levels of the ICS through formalised roles;
  • These roles are remunerated to ensure parity of availability and voice with NHS Trusts, NHS staff, social care and public health colleagues;
  • Existing statutory Local Representative Committees (such as LPCs) have the right put forward nominations for those roles; and
  • ICBs and Integrated Care Partnerships (ICPs) are required to publicly explain when they choose not to heed advice from local primary care bodies.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less